| John Charles Peacock Jr, MD | |
|
1118 Ross Clark Cir, 500, Dothan, AL 36301-3001 | |
| (334) 794-4159 | |
| (334) 792-7019 |
| Full Name | John Charles Peacock Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 28 Years |
| Location | 1118 Ross Clark Cir, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700883725 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 00023947 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeast Alabama Medical Center | Dothan, AL | Hospital |
| Medical Center Enterprise | Enterprise, AL | Hospital |
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Houston County Healthcare Authority | 9436062296 | 196 |
News Archive
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
Muscle Flex Inc. (PINKSHEETS: MFLI) (www.MuscleFlexInc.com) and Sterling Worldwide Entertainment, LLC (www.SterlingWWE.com), a subsidiary of Visual Industries, Inc., jointly announced today that their television show "Sugar Free," which is currently in pre-production, has received significant expressions of interest from global television program distributors and have engaged the interested media conglomerates in discussions regarding the show.
Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.
A discovery of a rare mutation that affects cholesterol has ignited hopes of a prescription that can help prevent heart attacks. In the meantime, the announcement by Roche could pose more questions about controversial diabetes medicines. Also a federal report warns Americans of using some Internet pharmacies.
› Verified 3 days ago
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
Muscle Flex Inc. (PINKSHEETS: MFLI) (www.MuscleFlexInc.com) and Sterling Worldwide Entertainment, LLC (www.SterlingWWE.com), a subsidiary of Visual Industries, Inc., jointly announced today that their television show "Sugar Free," which is currently in pre-production, has received significant expressions of interest from global television program distributors and have engaged the interested media conglomerates in discussions regarding the show.
Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.
A discovery of a rare mutation that affects cholesterol has ignited hopes of a prescription that can help prevent heart attacks. In the meantime, the announcement by Roche could pose more questions about controversial diabetes medicines. Also a federal report warns Americans of using some Internet pharmacies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Charles Peacock Jr, MD 1118 Ross Clark Cir, 500, Dothan, AL 36301-3001 Ph: (334) 794-4159 | John Charles Peacock Jr, MD 1118 Ross Clark Cir, 500, Dothan, AL 36301-3001 Ph: (334) 794-4159 |
News Archive
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
Muscle Flex Inc. (PINKSHEETS: MFLI) (www.MuscleFlexInc.com) and Sterling Worldwide Entertainment, LLC (www.SterlingWWE.com), a subsidiary of Visual Industries, Inc., jointly announced today that their television show "Sugar Free," which is currently in pre-production, has received significant expressions of interest from global television program distributors and have engaged the interested media conglomerates in discussions regarding the show.
Researchers at the University of California, Santa Barbara have discovered that attaching polymeric nanoparticles to the surface of red blood cells dramatically increases the in vivo lifetime of the nanoparticles.
A discovery of a rare mutation that affects cholesterol has ignited hopes of a prescription that can help prevent heart attacks. In the meantime, the announcement by Roche could pose more questions about controversial diabetes medicines. Also a federal report warns Americans of using some Internet pharmacies.
› Verified 3 days ago
Joseph Jason Phillips, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1118 Ross Clark Cir, 500, Dothan, AL 36301 Phone: 334-794-4159 Fax: 334-792-7019 | |
Mark Allen Byard, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 4370 W Main St, Dothan, AL 36305 Phone: 334-793-5000 Fax: 334-615-8418 | |
Joseph C Clements, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1118 Ross Clark Cir, 500, Dothan, AL 36301 Phone: 334-794-4159 Fax: 334-792-7019 | |
Jonathan G Vukovich, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1118 Ross Clark Cir, 500, Dothan, AL 36301 Phone: 334-794-4159 Fax: 334-792-7019 | |
Atwill Lamar Miller Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1908 Fairview Avenue, Dothan, AL 36301 Phone: 334-699-6863 | |
Mark W Fischer, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1118 Ross Clark Cir, 500, Dothan, AL 36301 Phone: 334-794-4159 Fax: 334-792-7019 |